Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-25-007749
Filing Date
2025-10-23
Accepted
2025-10-23 16:56:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA 14A sunshine_defa14a.htm DEFA14A 11970
2 GRAPHIC image_007.jpg GRAPHIC 112333
3 GRAPHIC image_008.jpg GRAPHIC 74944
  Complete submission text file 0001683168-25-007749.txt   271489
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-330-0684
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41282 | Film No.: 251413686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)